Drug Discovery

Medical laboratory
#Antibody drug conjugate (ADC) #Drug discovery #India

Globalising ADC development in the US and beyond

Srivats Rajagopal explores the growth of the antibody-body conjugate (ADC) market, development trends and why innovators are turning towards India. The ADC field has reached an inflection point. In 2022, Enhertu, Kadcyla, and Trodelvy together accounted for more than $4 billion of the $4.7 billion in global ADC revenues, and… Read More

#Exclusive Content

#Drug discovery

Getting Started Guide – Oxford Nanopore sequencing solutions for biopharma

Discover sequencing solutions that can be applied from biomarker discovery through to final product quality control (QC) testing, consolidating multiple legacy assays with one platform — and enabling faster, more confident decision-making. In this new getting started guide, you will:  Find out how Oxford Nanopore sequencing delivers the multiomic insight… Read More

#Guides

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery #Personalised medicine #Webinar

Register now: Innovative AI software solutions driving biomarker research

Biomarker discovery and validation are critical for advancing personalised medicine and improving therapeutic outcomes. However, the complexity of high-throughput assays and image-based analyses presents significant challenges in extracting meaningful insights efficiently. Taking place on 23 October at 4pm BST, this webinar, hosted by DDW and supported by Danaher Life… Read More

Webinar date:
Supported by Danaher
#News

Tower Bridge, London
#DDW Turning Science into Business Symposium #Drug discovery #Events #The Francis Crick Institute

Neuroscience expert to speak at DDW Symposium

Join DDW Editor Reece Armstrong and an expert line-up at the DDW Turning Science into Business Symposium at the Francis Crick Institute in London on Tuesday 4 November. This free half-day event will feature six in-depth presentations from industry experts, a panel discussion examining new… Read More

#News

#Astellas Pharma #Drug discovery #Interview #Ophthalmology

Astellas’ holistic strategy for drug discovery and development

Megan Thomas spoke to Leon Moore, Head of Global Brand Strategy & Marketing at Astellas, about how the company’s new Asset Maximization Teams are fostering collaboration and improving outcomes. MT: Astellas recently implemented a new structure, for its research, development and commercial teams to get innovative medicines to patients,… Read More

#Business & Investment #Exclusive Content

Structure of a molecule
#Drug discovery #Small molecules #Webinar

Quality drug candidates in under two years

Join this free webinar, hosted by DDW, to learn how Evotec is planning to shorten timelines for small molecule drug discovery projects. Using its ‘Every Compound a Candidate (ECC)’ approach, Evotec is aiming to reduce timelines to under two years. This webinar on 10 November 2025 will explore the… Read More

Webinar date:
Supported by Evotec
#News

Cancer cells
#Chemotherapy #Drug discovery #Neuropathy #Oncology

Reducing the side-effects of chemotherapy  

DDW speaks to Yasuo Nakamura, Senior Executive Officer at Pharmaceuticals R&D, Asahi Kasei Pharma Corporation about the challenges of treating chemotherapy-induced peripheral neuropathy (CIPN) and the company’s current pipeline targeting the condition.   DDW: What makes chemotherapy-induced peripheral neuropathy (CIPN) such a persistent challenge in colorectal cancer care, and why has… Read More

#Exclusive Content

#AI #Antibody #Drug discovery #GPCRs

Abalone Bio talks opportunities for GPCR targets  

DDW Editor Reece Armstrong speaks to Richard Yu, CEO and Co-Founder of Abalone Bio about the company’s efforts to develop antibody antagonists for GPCR targets.  RA: What have been the biggest challenges of developing GPCR therapeutics?  RY: The number one challenge is specificity, and it plays out in… Read More

#Exclusive Content

Antibody drug conjugate
#Antibody drug conjugate (ADC) #Drug discovery #Organoids

Factsheet: Discover how organoids are advancing ADC research

Unlock insights into ADC development with HUB Organoids’ new factsheet on patient-derived organoids, available to download now. Discover how advanced 3D tumour models are transforming preclinical testing and supporting safer, more effective antibody-drug conjugates. What you’ll learn: How organoids outperform traditional preclinical models for ADCs Strategies for evaluating efficacy,… Read More

#News

#Antibody drug conjugate (ADC) #Drug discovery #Organoids

Advance Your ADC Research – Organoids Vs. Traditional Models

Unlock insights into ADC development with HUB Organoids’ factsheet on patient-derived organoids. Discover how advanced 3D tumour models are transforming preclinical testing and supporting safer, more effective antibody-drug conjugates. What you’ll learn: How organoids outperform traditional preclinical models for ADCs Strategies for evaluating efficacy, safety, and biomarker discovery Real-world case… Read More

#Resources

India on globe
#Drug development #Drug discovery #India #Investment

Syngene International commits new investment to drug discovery

Syngene International has announced new investment in peptide laboratory and advanced automation to accelerate drug discovery and development in India.  The investments include a dedicated peptide laboratory in Bengaluru and the integration of automation across Drug Metabolism and Pharmacokinetics (DMPK) and Direct-to-Biology (D2B) workflows in Hyderabad. The… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery #Personalised medicine #Webinar

Webinar: Enhance the efficiency of your biomarker research

Biomarker discovery and validation are critical for advancing personalised medicine and improving therapeutic outcomes. However, the complexity of high-throughput assays and image-based analyses presents significant challenges in extracting meaningful insights efficiently. Taking place on 23 October at 4pm BST, this webinar, hosted by DDW and supported by Danaher Life… Read More

Webinar date:
Supported by Danaher
#News

#DDW Turning Science into Business Symposium #Drug discovery #Events #The Francis Crick Institute

DDW Symposium: Full programme announced

Join DDW Editor Reece Armstrong and an expert line-up at the DDW Turning Science into Business Symposium at the Francis Crick Institute in London on Tuesday 4 November. This free half-day event will feature six in-depth presentations from industry experts, a panel discussion examining new… Read More

#News